Assay method for Alzheimer's disease

Details for Australian Patent Application No. 2008202875 (hide)

Owner Washington University Eli Lilly and Company

Inventors Bales, Kelly R; Paul, Steven M; Demattos, Ronald; Cummins, David J; Holtzman, David M

Agent Spruson & Ferguson

Pub. Number AU-B-2008202875

Parent 2002329775

Filing date 30 June 2008

Wipo publication date 24 July 2008

Acceptance publication date 11 November 2010

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 49/00 (2006.01) Preparations for testing

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

17 July 2008 Complete Application Filed

24 July 2008 Application Open to Public Inspection

  Published as AU-B-2008202875

11 November 2010 Application Accepted

  Published as AU-B-2008202875

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202876-Anti-kickback device

2008202874-Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same